Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 7Breast 6Lymphoid 5Other hematologic neoplasm 4Gastrointestinal 4Genitourinary 3Head & Neck 2CNS 1

Conditions

Radiation Injuries 1Nasopharyngeal Carcinoma 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Brain Injuries 1

Interventions

Cisplatin 620pembrolizumab 323Radiotherapy 319Cetuximab 275Docetaxel 221Radiotherapy, Intensity-Modulated 210Carboplatin 197Fluorouracil 196Paclitaxel 159Nivolumab 138Gemcitabine 124Magnetic Resonance Spectroscopy 94Radiation 85Drug Therapy 77Capecitabine 76toripalimab 75Surgical Procedures, Operative 62durvalumab 60Biopsy 52Cyclophosphamide 50Chemoradiotherapy 47camrelizumab 46Specimen Handling 46Erlotinib Hydrochloride 46Radiosurgery 45130-nm albumin-bound paclitaxel 44Standard of Care 43tislelizumab 42Platinum 41Bevacizumab 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Steroids × Head & Neck × Clear all
NCT01874860 2022-12-01

Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients

University of Louisville

Phase 2 Completed
24 enrolled
GastrointestinalHead & Neck

Head and Neck Neoplasms, Colorectal Neoplasms

NCT04553510 2020-09-17

Treatment of Bevacizumab Followed by Steroid in RN

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Unknown
86 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Brain Injuries, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡